Most Recent
GSK defeats challenge to breakthrough RSV vaccine patent
Intellectual Property 2018-11-26 9:39 pm By Cat Fredenburgh

GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5